Authors: Tang Ran, Tang Jiyang, Han Xinyao, Zhang Linqi, Li Xiaoxin, Zhao Mingwei, Qu Jinfeng DOI: 10.3760/cma.j.cn115989-20220117-00023 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 53-59. Abstract [Download PDF] [Read Full Text] Objective To assess the efficacy and safety of […]
Tag: Conbercept
Evaluation of efficacy of combination therapy of intravitreal conbercept with posterior sub-Tenon triamcinolone acetonide for treatment of macular edema secondary to non-ischemic branch retinal vein occlusion
Authors: Xie Rui, Yuan Li DOI: 10.3760/cma.j.cn115989-20200229-00124 Published 2022-12-10 Cite as Chin J Exp Ophthalmol, 2022, 40(12): 1149-1156. Abstract [View PDF] [Read Full Text] Objective To evaluate the efficacy of combination therapy of intravitreal conbercept (IVC) with posterior sub-Tenon injection of triamcinolone […]
Comparison of the efficacy of conbercept and intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema
Auhtors: Gao Rongyu, Liu Jiandong, Zhu Fangxing, Yang Juanjuan, Xu Enpei, Xu Xinyan DOI: 10.3760/cma.j.cn115989-20200225-00108 Published 2022-07-10 Cite asChin J Exp Ophthalmol, 2022, 40(7): 658-663. Abstract [View PDF] [Read Full Text] Objective To compare the efficacy and safety of intravitreal injection of […]
Comparison of efficacy between intravitreal injection of conbercept with and without macular photocoagulation for diabetic macular edema
Authors: Jiang Li, Luo Xiaoling, Qin Bo, Deng Tingming, Yang Mingming DOI: 10.3760/cma.j.cn115989-20201104-00746 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 41-46. Abstract [View PDF] [Read Full Text] Objective To compare the clinical efficiency and safety between intravitreal injection of conbercept […]
Efficacy and safety of conbercept for choroidal neovascularization secondary to chronic central serous chorioretinopathy
Auhtors: Mao Jianbo, Zhang Caiyun, Shen Lijun, Lao Jimeng, Shao Yirun, Wu Hanfei, Chen Yiqi, Tao Jiwei DOI: 10.3760/cma.j.cn115989-20201104-00742 Published 2021-01-10 Cite as Chin J Exp Ophthalmol, 2021,39(01): 42-46. Abstract [View PDF] [Read Full Text] Objective To evaluate the efficacy and […]
A Meta-analysis of the effects of intravitreal conbercept as an adjunct before vitrectomy in proliferative diabetic retinopathy
Authors: Si Xia, Sun Chufeng, Chen Yue, Feng Wanyu, Feng Yufei DOI: 10.3760/cma.j.cn115989-20200715-00498 Published 2020-09-10 Cite as Chin J Exp Ophthalmol, 2020,38(09): 773-780. Abstract [View PDF] [Read Full Text] Objective To evaluate the efficacy and safety of preoperative intravitreal conbercept (IVC) as an adjunct to […]
Inhibiting effect of subconjuctivally injected conbercept on experimental corneal neovascularization and lymphangiogenesis in rabbit
Authors: Chen Xiaoxia, Li Jing, Gu Zhencheng DOI: 10.3760/cma.j.cn115989-20190327-00149 Published 2020-07-10 Cite as Chin J Exp Ophthalmol, 2020,38(07): 581-588. Abstract [View PDF] [Read Full Text] Objective To investigate the value of conbercept in experimental corneal nevascularization (CNV) and lymphangiogenesis in rabbit model. Methods Forty-four adult New […]
Clinical safety and efficacy of conbercept intravitreal injection on high myopic choroidal neovascularization
Authors: Jiao Mingfei, Li Xiaorong DOI: 10.3760/cma.j.issn.2095-0160.2016.08.013 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 725-728. Abstract [Download PDF] [Read Full Text] Background choroidal neovascularization (CNV) is the common reason of visual acuity impairment in high myopia patients, which usually leads to irreversible central visual impairment. […]
Effects of intravitreal injection of conbercept on vitrectomy for proliferative diabetic retinopathy
Authors: Zeng Guangchuan, Li Pingping, Ye Yangjun DOI: 10.3760/cma.j.issn.2095-0160.2017.10.014 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 920-923. Abstract [Download PDF] [Read Full Text] Background Pars plana vitrectomy (PPV) is the main therapy for advanced stage of proliferative diabetic retinopathy (PDR). Intravitreal injection […]
Clinical effect of vitreoretinal surgery combined with intravitreal injection of conbercept or ranibizumab on severe proliferative diabetic retinopathy
Authors: Guo Jing, Chen Song, Wang Yun, Liang Xu DOI: 10.3760/cma.j.issn.2095-0160.2017.10.013 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 914-919. Abstract [Download PDF] [Read Full Text] Background Vitreoretinal surgery (VRS) is the main treatment of severe proliferative diabetic retinopathy (PDR), intravitreal injection of anti-VEGF drugs before VRS on […]